Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder

NCT ID: NCT04730011

Last Updated: 2025-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-01

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obsessive-compulsive disorders are very damaging illnesses; they can already appear in childhood and adolescence and become extremely chronic. With an average prevalence from 1-3%, they are among the most common psychiatric disorders in children and adolescents. 40% of diagnosed children and young adults display persistent and increasingly chronic symptoms and O-C disorders are highly complex syndromes with broadly varying manifestations. They arise from obsessive thoughts (ideas/thoughts or impulses, often senseless or tortured, that impose themselves or intrude) and obsessive behavior (ritualized patterns that must be frequently repeated).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obsessive-Compulsive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment Group

Patients are treated based on the Cognitive Behavioral Psychotherapy. This includes individual and group sessions over one week.

Group Type EXPERIMENTAL

Short and Intensive Treatment

Intervention Type BEHAVIORAL

Intensive Treatment Week with behavioural psychotherapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Short and Intensive Treatment

Intensive Treatment Week with behavioural psychotherapy

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Obsessive-Compulsive Disorder diagnosis
* Male and female patients from 8-18 years
* Good German language speaking skills
* IQ of at least 75
* At least four days' participation in the treatment/therapy week
* Written agreement after clear explanation

Exclusion Criteria

\- No complete participation in the intensive week treatment/therapy
Minimum Eligible Age

8 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Susanne Walitza

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Susanne Walitza

Head of the Department of Child and Adolescent Psychiatry

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Susanne Walitza, Prof. Dr. med. Dipl.-Psych.

Role: PRINCIPAL_INVESTIGATOR

Sponsor GmbH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Psychiatric University Clinics, Department of Child and Adolescent Psychiatry

Zurich, Canton of Zurich, Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Susanne Walitza, Prof. Dr. med. Dipl.-Psych.

Role: CONTACT

+41 (0)43 499 26 26

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Susanne Walitza, Prof. Dr. med. Dipl.-Psych.

Role: primary

+41 43 499 26 26

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KJPP 2020-02053

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Developing Computerised CBT for Adults With OCD
NCT02398045 UNKNOWN EARLY_PHASE1
Short Term Group Therapy for OCD
NCT00229320 COMPLETED NA